S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
ASX:MVP

Medical Developments International Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume169,499 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.77%
BetaN/A

Receive MVP News and Ratings via Email

Sign-up to receive the latest news and ratings for Medical Developments International and its competitors with MarketBeat's FREE daily newsletter.


About Medical Developments International

Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company operates through three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management for use in home or in hospitals; Penthrox, a prescription only medicine for pain relief; medical devices; and various veterinary anesthetic machines to veterinarians. The company operates in Australia, New Zealand, the United Kingdom, rest of Europe, Canada, the Middle East, Asia, South Africa, North America, and internationally. Medical Developments International Limited was incorporated in 2003 and is headquartered in Scoresby, Australia.

Headlines

Bullish Medical Developments International Limited (ASX:MVP) insiders filled their treasuries with AU$2.8m worth of stock over last year
September 22, 2021 |  finance.yahoo.com
Personalis Receives New VA MVP Task Order and...
September 21, 2021 |  benzinga.com
Medical Developments International Limited (ASX:MVP) Insider Buys A$19,950.00 in Stock
September 7, 2021 |  americanbankingnews.com
Medical Developments (ASX:MVP) share price hits new 52 week low
September 6, 2021 |  fool.com.au
Medical Developments (ASX:MVP) share price falls on $13 million loss
August 25, 2021 |  msn.com
Medical Developments International Ltd.
August 4, 2021 |  barrons.com
What Kind Of Shareholders Hold The Majority In Medical Developments International Limited's (ASX:MVP) Shares?
July 23, 2021 |  finance.yahoo.com
Why the Medical Developments International (ASX:MVP) share price is sinking 8% today
July 15, 2021 |  fool.com.au
Beacons of truth and hope
July 14, 2021 |  msn.com
Power 50: The third group of profiles from the 2021 list
June 21, 2021 |  bizjournals.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
Current Symbol
ASX:MVP
Previous Symbol
CUSIP
N/A
CIK
N/A
Web
www.medicaldev.com
Phone
61 3 9547 1888
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
$25.27 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
21.37
Book Value
A$0.96 per share
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
4.46
Current Ratio
6.81
Quick Ratio
5.93

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
N/A
Market Cap
N/A
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

1.21 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Medical Developments International (ASX:MVP) Frequently Asked Questions

What stocks does MarketBeat like better than Medical Developments International?

Wall Street analysts have given Medical Developments International a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medical Developments International wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Is Medical Developments International a good dividend stock?

Medical Developments International pays an annual dividend of A$0.04 per share and currently has a dividend yield of 0.77%.
View Medical Developments International's dividend history.

Who are Medical Developments International's key executives?

Medical Developments International's management team includes the following people:
  • Mr. Mark Edwards C.A., BAcc, CA, CFO & Company Sec.
  • Mr. Brent MacGregor, Chief Exec. Officer (Age 57)
  • Matthew Cramer, Chief of Operations & Supply Chain
  • Thomas Materia, Head of Sales & Marketing
  • Tara Collier, Head of HR
  • Dr. Scott Courtney, Chief Scientific Officer
  • Michelle Bradney, Head of Medical Affairs
  • Wai Ng Chi, Head of Regulatory Affairs
  • Neil Issa, Head of Quality
  • Wayne Pearce, Head of Production

What other stocks do shareholders of Medical Developments International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Developments International investors own include Talon Energy (TPD), Mesoblast (MESO), Gold Road Resources (GOR), Elixinol Wellness (ELLXF), Core Lithium (CXO) and Bubs Australia (BUB).

What is Medical Developments International's stock symbol?

Medical Developments International trades on the ASX under the ticker symbol "MVP."

How much money does Medical Developments International make?

Medical Developments International has a market capitalization of $0.00 and generates $25.27 million in revenue each year.

How many employees does Medical Developments International have?

Medical Developments International employs 65 workers across the globe.

What is Medical Developments International's official website?

The official website for Medical Developments International is www.medicaldev.com.

How can I contact Medical Developments International?

The company can be reached via phone at 61 3 9547 1888.


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.